Back
Celldex Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison
Sell
50
CLDX
Celldex Therapeutics
Last Price:
39.91
Seasonality Move:
8.94%
Buy
61
CATX
Perspective Therapeutics
Last Price:
1.54
Seasonality Move:
2.36%
Sell
50
Celldex Therapeutics (CLDX)
is a Sell
Is Celldex Therapeutics a Buy, Sell or Hold?
- The current Celldex Therapeutics [CLDX] share price is $39.94. The Score for CLDX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- CLDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $1.53. The Score for CATX is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- CATX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CLDX Stock Price Chart
What is Celldex Therapeutics's stock price today?
-
The Celldex Therapeutics share price today is $39.94
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLDX is experiencing slight buying pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $1.53
The current trend is moderately bearish and CATX is experiencing slight buying pressure.
CLDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 49.69 | Sell |
| Chaikin Money Flow: | 210037 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.57 - 41.01) | Buy |
| Bollinger Bands (100): | (36.8 - 44.2) | Sell |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 44.05 | Sell |
| Chaikin Money Flow: | 1336950 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.51 - 1.77) | Sell |
| Bollinger Bands (100): | (0.65 - 1.51) | Buy |
CLDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.51 | Sell |
| 20-day SMA: | 39.36 | Buy |
| 50-day SMA: | 40.7 | Sell |
| 200-day SMA: | 34.6 | Buy |
| 8-day EMA: | 40.15 | Sell |
| 20-day EMA: | 39.97 | Sell |
| 50-day EMA: | 40.11 | Sell |
| 200-day EMA: | 37.23 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.72 | Sell |
| 20-day SMA: | 1.69 | Sell |
| 50-day SMA: | 1.45 | Buy |
| 200-day SMA: | 0.7 | Buy |
| 8-day EMA: | 1.67 | Sell |
| 20-day EMA: | 1.65 | Sell |
| 50-day EMA: | 1.46 | Buy |
| 200-day EMA: | 0.9 | Buy |
Celldex Therapeutics Earnings Growth & CLDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.23 per share, an increase this year of $0.25 per share, and a decrease next year of $0.34 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Celldex Therapeutics Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||